This narrative review examines the FAM13A gene in several lung conditions, including chronic obstructive pulmonary disease, pulmonary fibrosis, asthma, and lung cancer. The study was not based on a specific group of patients or a clinical trial but rather analyzed existing scientific information.
The authors found that FAM13A is associated with tissue destruction in chronic obstructive pulmonary disease. In contrast, the same gene appears linked to mitigated fibrotic remodeling in pulmonary fibrosis. These findings highlight how the gene might function differently depending on the specific lung disease present.
The review notes several limitations, such as the complexity of the gene's multiple splice variants and differences in how it is expressed between species. Because this is a narrative review, the results are not based on new patient data and should be viewed as a starting point for future research rather than immediate clinical guidance.